Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 4, 2007, Pages 269-273

  Newall, Fiona ^a   Browne, Martin ^a   Savoia, Helen ^a   Campbell, Janine ^a   Barnes, Chris ^a   Monagle, Paul ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Outcome; Thromboembolism; Thrombolytic therapy

Indexed keywords

ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FIBRINOLYTIC THERAPY; HEMATURIA; HUMAN; INFANT; NEWBORN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 34247170853     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318047b78b     Document Type: Article

References (17)

1. Farnoux C, Odile C, Pinquier D, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatrics. 1998;133:137-140.
2. Ferrari F, Vagnarelli F, Gargano G, et al. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Childhood Fetal Neonatal Ed. 2001;85:F66-F72.
3. Weiner G, Castle V, DiPietro M, et al. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatrics. 1998;133:133-136.
4. Gupta A, Leaker M, Andrew M, et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatrics. 2001;139:682-688.
5. Levine M, Raskob G, Beyth R, et al. Hemorrhagic complications of anticoagulant treatment. Chest. 2004;126:287S-310S.
6. Monagle P, Chan A, Chalmers E, et al. Antithrombotic therapy in children. Chest. 2004;126(3 suppl):645S-687S.
7. Albisetti M. Thrombolytic therapy in children. Thrombosis Res. 2006;188:95-105.
8. Hartmann J, Hussein A, Trowitzsch E. Treatment of neonatal thrombux formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Childhood Fetal Neonatal Ed. 2001;85:F18-F22.
9. Manco-Johnson M, Nuss R, Hays T, et al. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatrics. 2000;136:446-453.
10. Wang M, Hays T, Balasa V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003;25:379-386.
11. Francis CW, Totterman S. Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy. Thrombosis Haemostasis. 1995;73:386-391.
12. Revel-Vilk S, Sharathkumar A, Massicotte P, et al. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thrombosis Haemostasis. 2004;2:42-46.
13. Male C, Chait P, Ginsberg J, et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic antithrombin replacement in kids with ALL treated with asparaginase. Thrombosis Haemostasis. 2002;87:593-598.
14. Chait P, Dinyari M, Massicotte P. The sensitivity and specificity of lineograms and ultrasound compared to venograpy for the diagnosis of central venous line related thrombosis in symptomatic children: the LUV study. Thrombosis Haemostasis. 2001;86(suppl 1). Abstract P697.
15. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report form the Canadian childhood thrombophilia registry. Pediatric Res. 2000;47:763-766.
16. Newall F, Campbell J, Savioa H, et al. Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy. Sydney, Australia: International Society of Thrombosis and Haemostasis; 2005.
17. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood. 1999;94:3007-3014.